U.S. Markets closed
  • S&P 500

    3,783.28
    -7.65 (-0.20%)
     
  • Dow 30

    30,273.87
    -42.43 (-0.14%)
     
  • Nasdaq

    11,148.64
    -27.76 (-0.25%)
     
  • Russell 2000

    1,762.69
    -13.08 (-0.74%)
     
  • Crude Oil

    88.01
    +0.25 (+0.28%)
     
  • Gold

    1,725.50
    +4.70 (+0.27%)
     
  • Silver

    20.64
    +0.09 (+0.44%)
     
  • EUR/USD

    0.9897
    -0.0089 (-0.8907%)
     
  • 10-Yr Bond

    3.7590
    +0.1420 (+3.93%)
     
  • Vix

    28.55
    -0.52 (-1.79%)
     
  • GBP/USD

    1.1337
    -0.0138 (-1.1995%)
     
  • USD/JPY

    144.4900
    +0.2910 (+0.2018%)
     
  • BTC-USD

    20,153.55
    -143.25 (-0.71%)
     
  • CMC Crypto 200

    456.09
    -2.31 (-0.50%)
     
  • FTSE 100

    7,052.62
    -33.84 (-0.48%)
     
  • Nikkei 225

    27,120.53
    +128.33 (+0.48%)
     

Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

·1 min read

NEW BRUNSWICK, N.J., August 09, 2022--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005996/en/

Contacts

Media Contact:

Jake Sargent
(732) 524-1090

Investor Contacts:

Lisa Romanko
(732) 524-2034

Sarah Wood
(732) 524-2617